Ebola Literature

Abramowitz SA, Hipgrave DB, Witchard A, et al. Lessons from the West Africa Ebola epidemic: a systematic review of epidemiological and social behavioral science research priorities. J Infect Dis 2018 (published online Jun 23)

Anywaine Z, Whitworth H, Kaleebu P, et al. Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania. J Infect Dis 2019 (published online Feb 23)

Barry A, Ahuka-Mundeke S, Ahmed YA, et al (Ebola Outbreak Epidemiology Team). Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study. Lancet 2018 (published online Jun 29)

Bolay FK, Grandits G, Lane HC, et al. PREVAIL I cluster vaccination study with rVSVG-ZEBOV-GP as part of a public health response in Liberia. J Infect Dis 2018 (published online Dec 17)

Bornholdt ZA, Herbert AS, Mire CE, et al. A two-antibody pan-Ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates. Cell Host Microb 2019 Jan 9;25(1):49-58

Bramble MS, Hoff N, Gilchuk P, et al. Pan-filovirus serum neutralizing antibodies in a subset of Congolese Ebolavirus infection survivors. J Infect Dis 2018 (published online Aug 13)

Brannan JM, He S, Howell KA, et al. Post-exposure immunotherapy for two Ebolaviruses and Marburg virus in nonhuman primates. Nat Commun 2019 (published online Jan 10)

Brown JF, Dye JM, Tozay S, et al. Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with Ebola virus disease. J Infect Dis 2018 (published online Apr 11)

Carter RJ, Idriss A, Widdowson MA, et al. Implementing a multisite clinical trial in the midst of an Ebola outbreak: lessons learned from the Sierra Leone Trial to Introduce a Vaccine against Ebola. J Infect Dis 2018 May 18;217(suppl 1):S16-23

Carter RJ, Senesi RGB, Dawson P, et al. Participant retention in a randomized clinical trial in an outbreak setting: lessons from the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE). J Infect Dis 2018 May 18;217(suppl 1):S65-74

Claude KM, Underschultz J, Hawkes MT. Ebola virus epidemic in war-torn eastern DR Congo. (Letter) Lancet 2018 (published online Oct 5)

Conteh MA, Goldstein ST, Wurie HR, et al. Clinical surveillance and evaluation of suspected Ebola cases in a vaccine trial during an Ebola epidemic: the Sierra Leone Trial to Introduce a Vaccine against Ebola. J Infect Dis 2018 May 18;217(suppl 1):S33-9

De Nys HM, Kingebeni PM, Keita AK, et al. Survey of Ebola viruses in frugivorous and insectivorous bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015-2017. Emerg Infect Dis 2018 (published online Oct 11)

Demetria C, Smith I, Tan T, et al. Reemergence of Reston ebolavirus in cynomolgus monkeys, the Philippines, 2015. Emerg Infect Dis 2018 (published online May 22)

Den Boon S, Marston BJ, Nyenswah TG, et al. Ebola virus infection associated with transmission from survivors. Emerg Infect Dis 2018 (published online Nov 30)

Diallo B, Van Gucht S, Musa EO, et al. Ebola virus transmission caused by persistently infected survivors of the 2014-2016 outbreak in West Africa. J Infect Dis 2018 (published online Jun 18)

Dokubo EK, Wendland A, Mate SE, et al. Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report. Lancet Infect Dis 2018 (published online Jul 23)

Feng S, Grepin KA, Chunara R. Tracking health seeking behavior during an Ebola outbreak via mobile phones and SMS. NPJ Digit Med 2018 Oct 2;1(51)

GAO. Ebola recovery: USAID has initiated or completed most projects, but a complete project inventory is still needed for evaluating its efforts. GAO-18-350. Mar 28, 2018

Garibaldi BT, Ruparelia C, Shaw-Saliba K, et al. A novel personal protective equipment coverall was rated higher than standard Ebola virus personal protective equipment in terms of comfort, mobility and perception of safety when tested by health care workers in Liberia and in a United States biocontainment unit. Am J Infect Control 2018 (published online Oct 6)

Gatiso TT, Ordaz-Nemeth I, Grimes T, et al. The impact of the Ebola virus disease (EVD) epidemic on agricultural production and livelihoods in Liberia. PLoS Negl Trop Dis 2018 Aug 2;12(8):e0006580

Goldstein T, Anthony SJ, Gbakima A, et al. The discovery of Bombali virus adds further support for bats as hosts of Ebolaviruses. Nat Microbiol 2018 (published online Aug 27)

Gray N, Stringer B, Bark G, et al. 'When Ebola enters a home, a family, a community': a qualitative study of population perspectives on Ebola control measures in rural and urban areas of Sierra Leone. PLoS Negl Trop Dis 2018 Jun 8;12(6):e0006461

Guedj J, Piorkowski G, Jacquot F, et al. Antiviral efficacy of favipiravir against Ebola virus: a translational study in cynomolgus macaques. PLoS Med 2018 Mar 27;15(3):e1002535

HHS OIG. Hospitals reported improved preparedness for emerging infectious diseases after the Ebola outbreak. Oct 16, 2018

Hoff NA, Mukadi P, Doshi RH, et al. Serologic markers for Ebolavirus among healthcare workers in the Democratic Republic of the Congo. J Infect Dis 2018 (published online Sep 19)

Howlett PJ, Walder AR, Lisk DR, et al. Case series of severe neurologic sequelae of Ebola virus disease during epidemic, Sierra Leone. Emerg Infect Dis 2018 (published online Jul 11)

Huber C, Finelli L, Stevens W. The economic and social burden of the 2014 Ebola outbreak in West Africa. J Infect Dis 2018 (published Oct 13)

Huizenga E, van der Ende J, Zwinkels N, et al. A modified case definition to facilitate essential hospital care during Ebola outbreaks. Clin Infect Dis 2018 (published online Sep 18)

Huttner A, Agnandji ST, Combescure C, et al. Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study. Lancet Infect Dis 2018 (published online Apr 4)

J Infect Dis. Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). J Infect Dis supplement 2018 May 18;217(suppl 1)

Jalloh MF, Jalloh MB, Albert A, et al. Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone. Vaccine 2019 (published online Feb 10)

James AS, Todd S, Pollak NM, et al. Ebolavirus diagnosis made simple, comparable and faster than molecular detection methods: preparing for the future. Virol J 2018 Apr 23;15:75

Jarrett OD, Seward JF, Fombah AE, et al. Monitoring serious adverse events in the Sierra Leone Trial to Introduce a Vaccine against Ebola. J Infect Dis 2018 May 18:217(suppl 1):S24-32

Jennings BM, Yeager KA, Feistritzer NR, et al. Enacting high reliability principles while caring for people with Ebola virus disease. Am J Infect Control 2018 (published online May 18)

Juan-Giner A, Tchaton M, Jemmy JP, et al. Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea. Vaccine 2018 (published online Sep 25)

Jusu MO, Glauser G, Seward JF, et al. Rapid establishment of a cold chain capacity of -60˚C or colder for the STRIVE Ebola vaccine trial during the Ebola outbreak in Sierra Leone. J Infect Dis 2018 May 18;217(suppl 1):S48-55

Kapetshi J, Fausther-Bovendo H, Corbett C, et al. Contribution of environment sample-based detection to Ebola outbreak management. J Infect Dis 2018 (published online Oct 16)

Kelly JD, Weiser SD, Wilson B, et al. Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: an observational cohort study. PLOS Negl Trop Dis 2019 Feb 27;13(2):e0007185

Luke T, Bennett RS, Gerhardt DM, et al. Fully human immunoglobulin G from transchromosomic bovines treats nonhuman primates infected with Ebola virus Makona isolate. J Infect Dis 2018 (published online Jul 16)

Lyman M, Mpofu JJ, Soud F, et al. Maternal and perinatal outcomes in pregnant women with suspected Ebola virus disease in Sierra Leone, 2014. Obstet Gynecol 2018 (published online Mar 23)

Mallow M, Gary L, Jeng T, et al. WASH activities at two Ebola treatment units in Sierra Leone. PLoS One 2018 May 24;13(5):e0198235

Marz A, Chadinah S, Haddock E, et al. Recently identified mutations in the Ebola virus-Makona genome do not alter pathogenicity in animal models. Cell Rep 2018 May 8;23(6):1806-16

McElroy AK, Shrivastava-Ranjan P, Harmon JR, et al. Macrophage activation marker soluble CD163 associated with fatal and severe Ebola virus disease in humans. Emerg Infect Dis 2019 (published online Jan 16)

Morin C, Bost I, Mercier A, et al. Information circulation in times of Ebola: Twitter and the sexual transmission of Ebola by survivors. PLoS Curr 2018 (published online Aug 28)

Mutua G, Anzala O, Luhn K, et al. Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya. J Infect Dis 2019 (published online Feb 23)

Odlum M, Yoon S. Health information needs and health seeking behavior during the 2014-2016 Ebola outbreak: a Twitter content analysis. PLoS Curr 2018 (published online Mar 23)

Overholt L, Wohl DA, Fischer WA II, et al. Stigma and Ebola survivorship in Liberia: results from a longitudinal cohort study. PLOS One 2018 Nov 28;13(11):e0206595

Pascal KE, Dudgeon D, Trefry JC, et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. J Infect Dis 2018 (published online May 31)

Pascal KE, Dudgeon D, Trefry JC, et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. J Infect Dis 2018 (published online May 31)

Patel A, Reuschel EL, Kraynyak KA, et al. Protective efficacy and long-term immunogenicity in cynomolgus macaques by Ebola virus glycoprotein synthetic DNA vaccines. J Infect Dis 2018 (published online Oct 10)

Peters JL, Cho DK, Aluisio AR, et al. Environmental temperature and case fatality of patients with Ebola virus disease in Sierra Leone and Liberia, 2014-2015: a retrospective cohort study. Trop Med Int Health 2018 (published online Oct 11)

Pini A, Zomahoun D, Duraffour S, et al. Field investigation with real-time virus genetic characterization support of a cluster of Ebola virus disease cases in Dubreka, Guinea, April to June 2015. Euro Surveill 2018 Mar 22;23(12):pii=17-00140

Poetsch JH, Dahlke C, Zinser ME, et al. Detectable vesicular stomatitis virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humans. J Infect Dis 2018 (published online Nov 17)

PREVAIL Study Group. A longitudinal study of Ebola sequelae in Liberia. N Engl J Med 2019 Mar 7;380(10):924-34

Regner I, Ianos OE, Shajrawi L, et al. Travelers' actual and subjective knowledge about risk for Ebola virus disease. (Research letter) Emerg Infect Dis 2018 (published online Jul 23)

Reichler MR, Bangura J, Bruden D, et al. Household transmission of Ebola virus: risks and preventive factors, Freetown, Sierra Leone, 2015. J Infect Dis 2018 (published online Apr 6)

Reusken CB, Mogling R, Smit PW, et al. Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet. Euro Surveill 2018 May 10;23(19):pii=17-00404

Rosenke K, Bounds CE, Hanley PW, et al. Human polyclonal antibodies produced by transchromosomal cattle provide partial protection against lethal Zaire Ebolavirus challenge in rhesus macaques. J Infect Dis 2018 (published online Jul 25)

Samai M, Seward JF, Goldstein ST, et al. The Sierra Leone Trial to Introduce a Vaccine Against Ebola: an evaluation of rVSVΔG-ZEBOV-GP vaccine tolerability and safety during the West Africa Ebola outbreak. J Infect Dis 2018 May 18;217(suppl 1):S6-15

Sebba D, Lastovich AG, Kuroda M, et al. A point-of-care diagnostic for differentiating Ebola from endemic febrile diseases. Sci Transl Med 2018 Dec 12;10(471)

Shantha JG, Mattia JG, Goba A, et al. Ebola virus persistence in ocular tissues and fluids (EVICT) study: reverse transcription-polymerase chain reaction and cataract surgery outcomes of Ebola survivors in Sierra Leone. EBioMedicine 2018 (published online Mar 23)

Sivapalasingam S, Kamal M, Slim R, et al. Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study. Lancet Infect Dis 2018 (published online Jun 18)

Speranza E, Bixler SL, Altamura LA, et al. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever. Sci Transl Med 2018 Mar 28;10(434):eaaq1016

Swanson KC, Altare C, Wesseh CS, et al. Contact tracing performance during the Ebola epidemic in Liberia, 2014-2015. PLoS Negl Trop Dis 2018 Sep 12;12(9):e0006762

Tariq A, Roosa K, Mizumoto K, et al. Assessing reporting delays and the effective reproduction number: the 2018-19 Ebola epidemic in DRC, May 2018-January 2019. Epidemics 2019 (published online Feb 3)

Venkatraman N, Ndiaye BP,Bowyer G, et al. Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen — ChAd3-EBO-Z followed by MVA-EBO-Z in healthy adults in the UK and Senegal. J Infect Dis 2018 (published online Nov 8)

Wang J, Wong G, Zhu W, et al. Equine-origin immunoglobulin fragments protects nonhuman primates from Ebola virus disease. J Virol 2018 (published online Dec 12)

Wec AZ, Bornholdt ZA, He S, et al. Development of a human antibody cocktail that deploys multiple functions to confer pan-Ebolavirus protection. Cell Host Microb 2019 Jan 9;25(1):39-48

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»